Approximately 1000 children 0-14 years of age are diagnosed with cancer each year in Canada, and over 100 children unfortunatley will die from the disease every year.
Compared to adult cancers, pediatric cancers are rare, accounting for less than 1% of newly diagnosed cases in Canada, however, childhood cancer remains the most common disease-related cause of death with brain tumors, leukemia and neuroblastoma representing the deadliest forms of malignancies for children up to fourteen years of age. Similarly, in the adolescent and young adult (AYA) population 15-39 years of age, leukemias and brain tumors account for the largest number of deaths.
The Children’s Hospital Research Institute of Manitoba has launched a new research theme, PROMISE, that will combine interdisciplinary, fundamental, translational, and clinical research conducted by highly qualified researchers with diverse expertise in hematologic and solid tumor pediatric and AYA malignancies, thus creating new and exciting networking and collaborative opportunities among theme members.
In addition, the PROMISE theme will bring together trainees with a common interest in pediatric and AYA oncology and enable them to present their work in a more focused forum.
Who We Are
Lead Investigator
Dr. Cedric Tremblay is an assistant professor in the department of immunology and a principal investigator at the Children’s Hospital Research Institute of Manitoba (CHRIM) and Paul Albrechtsen Research Institute CancerCare Manitoba.
In 2011, he relocated to the Australian Centre for Blood Diseases (ACBD) in the Stem Cell Research Group led by Professor David Curtis to complete his postdoctoral research on the stem-cell-like properties of relapse-inducing cells in acute leukemia.
He was appointed as a research fellow in 2015, thereby leading collaborative research projects investigating the mechanisms of drug resistance in acute leukemia.
Dr. Cedric Tremblay joined the Paul Albrechtsen Research Institute CancerCare Manitoba and the University of Manitoba in 2022.
Executive Leadership Team
Dr. Britt Drögemöller is an Assistant Professor in the Department of Biochemistry & Medical Genetics at the University of Manitoba. Dr. Drögemöller holds a Canada Research Chair in Pharmacogenomics and Precision Medicine and is appointed as a Research Scientist at The Children’s Hospital Foundation of Manitoba (CHRIM), an Adjunct Scientist at the Paul Albrechtsen Research Institute CancerCare Manitoba and a Research Affiliate at the Centre on Aging.
Dr. Sapna Oberoi is a CHRIM Scientist and Assistant professor in the Department of Pediatrics and Child Health at the University of Manitoba with cross appointments in Pediatric oncology/hematology BMT and Manitoba Adolescent and young adult oncology lead at CancerCare Manitoba.